Pulsed Radiofrequency neuromodulation of three nerves of shoulder joint with Glenohumeral joint hydrodistension vs Pulsed Radiofrequency neuromodulation of the Suprascapular nerve along with Glenohumeral joint hydrodistension for treatment of Adhesive Capsulitis

A Comparative Study between Pulsed Radiofrequency neuromodulation of three nerves of shoulder joint i.e Suprascapular, Axillary and Lateral pectoral nerve along with Glenohumeral joint hydrodistension vs Pulsed Radiofrequency neuromodulation of the Suprascapular nerve along with Glenohumeral joint hydrodistension for treatment of Adhesive Capsulitis. A Prospective Randomised Controlled trial - nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/104080

Enrollment

100

Registered

2026-02-17

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M95-M95- Other disorders of the musculoskeletal system and connective tissue

Interventions

Intervention1: Pulsed Radiofrequency neuromodulation of 3 nerves Suprascapular, Axillary and Lateral pectoral nerve along with Glenohumeral joint hydrodistension: Pulsed Radiofrequency neuromodulation

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with Chronic pain (existing for more than three months at the time of examination) in the shoulder diagnosed as Adhesive Capsulitis 2.Refractory to conservative treatment 3.Willing to give consent for study 4.The positive effect of the test blockade of the suprascapular, axillary and lateral thoracic nerves with a local anaesthetic (reduction of the pain level from the baseline according to NRS by at least 50%)

Exclusion criteria

Exclusion criteria: 1.Red flag signs- trauma leading to fracture, dislocation, complete tear, malignancy, septic arthritis 2.Allergy to local anaesthetics, drugs 3.Localized infection at site, Fever 4.Coagulopathy 5.Pregnant females 6.Patient on pacemakers 7.Instability of the shoulder joint 8.Cervical radiculopathy

Design outcomes

Primary

Measure	Time frame
1. Improvement in Pain (NRS score) 2. Functional activity of shoulder joint (SPADI score, Range of motion)Timepoint: 15 days and 3 months, 6 months and 12 months	—

Secondary

Measure	Time frame
Secondary outcome Any adverse effects (eg pain, infection, bleeding, paralysis) and duration of improvement.Timepoint: 15 days and 3 months, 6 months and 12 months	—

Countries

India

Contacts

Public ContactDr Samir Basak

CENTRAL HOSPITAL , SOUTH EASTERN RAILWAYS, GARDEN REACH, KOLKATA

drsamirbasak@gmail.com9002080538

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026